NF 546Selective P2Y11 agonist CAS# 1006028-37-0 |
- Tubastatin A HCl
Catalog No.:BCC3877
CAS No.:1310693-92-5
- Entinostat (MS-275,SNDX-275)
Catalog No.:BCC3595
CAS No.:209783-80-2
- M344
Catalog No.:BCC2162
CAS No.:251456-60-7
- Panobinostat (LBH589)
Catalog No.:BCC3601
CAS No.:404950-80-7
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 1006028-37-0 | SDF | Download SDF |
| PubChem ID | 73755075 | Appearance | Powder |
| Formula | C47H44N6Na4O17P4 | M.Wt | 1180.74 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Solubility | Soluble to 10 mM in water with gentle warming | ||
| Chemical Name | 4,4'-(Carbonylbis(imino-3,1-phenylen | ||
| SMILES | CC1=C(C=C(C=C1)C(=O)NC2=C(C=C(C=C2)CP(=O)(O)[O-])CP(=O)(O)[O-])NC(=O)C3=CC(=CC=C3)NC(=O)NC4=CC=CC(=C4)C(=O)NC5=C(C=CC(=C5)C(=O)NC6=C(C=C(C=C6)CP(=O)(O)[O-])CP(=O)(O)[O-])C.[Na+].[Na+].[Na+].[Na+] | ||
| Standard InChIKey | GSMUPMANKNAMAS-UHFFFAOYSA-J | ||
| Standard InChI | InChI=1S/C47H48N6O17P4.4Na/c1-27-9-13-33(45(56)50-39-15-11-29(23-71(59,60)61)17-35(39)25-73(65,66)67)21-41(27)52-43(54)31-5-3-7-37(19-31)48-47(58)49-38-8-4-6-32(20-38)44(55)53-42-22-34(14-10-28(42)2)46(57)51-40-16-12-30(24-72(62,63)64)18-36(40)26-74(68,69)70;;;;/h3-22H,23-26H2,1-2H3,(H,50,56)(H,51,57)(H,52,54)(H,53,55)(H2,48,49,58)(H2,59,60,61)(H2,62,63,64)(H2,65,66,67)(H2,68,69,70);;;;/q;4*+1/p-4 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | P2Y11 agonist (pEC50 = 6.27). Exhibits selectivity for P2Y11 over a range of P2Y and P2X receptors. |
NF 546 Dilution Calculator
NF 546 Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 0.8469 mL | 4.2346 mL | 8.4693 mL | 16.9385 mL | 21.1732 mL |
| 5 mM | 0.1694 mL | 0.8469 mL | 1.6939 mL | 3.3877 mL | 4.2346 mL |
| 10 mM | 0.0847 mL | 0.4235 mL | 0.8469 mL | 1.6939 mL | 2.1173 mL |
| 50 mM | 0.0169 mL | 0.0847 mL | 0.1694 mL | 0.3388 mL | 0.4235 mL |
| 100 mM | 0.0085 mL | 0.0423 mL | 0.0847 mL | 0.1694 mL | 0.2117 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- TAK-593
Catalog No.:BCC5142
CAS No.:1005780-62-0
- TC ASK 10
Catalog No.:BCC6301
CAS No.:1005775-56-3
- Monomethylsulochrin
Catalog No.:BCN7255
CAS No.:10056-14-1
- Tirasemtiv
Catalog No.:BCC5183
CAS No.:1005491-05-3
- LCL161
Catalog No.:BCC1691
CAS No.:1005342-46-0
- CVT 10216
Catalog No.:BCC5606
CAS No.:1005334-57-5
- Gelomulide N
Catalog No.:BCN6641
CAS No.:1005212-02-1
- Aeruginolactone
Catalog No.:BCN3695
CAS No.:1005208-88-7
- TCS 2002
Catalog No.:BCC6074
CAS No.:1005201-24-0
- Blasticidin A
Catalog No.:BCN1830
CAS No.:100513-53-9
- Sterigmatocystin
Catalog No.:BCN6885
CAS No.:10048-13-2
- Gastrin I (human)
Catalog No.:BCC5958
CAS No.:10047-33-3
- MK-2894
Catalog No.:BCC1757
CAS No.:1006036-87-8
- MK-2894 sodium salt
Catalog No.:BCC1758
CAS No.:1006036-88-9
- (-)-Epipinoresinol
Catalog No.:BCN3377
CAS No.:10061-38-8
- Desloratadine
Catalog No.:BCC4540
CAS No.:100643-71-8
- Ganoderenic acid A
Catalog No.:BCN3208
CAS No.:100665-40-5
- Ganoderenic acid B
Catalog No.:BCN7966
CAS No.:100665-41-6
- Ganoderenic acid C
Catalog No.:BCN3210
CAS No.:100665-42-7
- Ganoderenic acid D
Catalog No.:BCN2445
CAS No.:100665-43-8
- Deacetyl ganoderic acid F
Catalog No.:BCN2870
CAS No.:100665-44-9
- 3-(Hydroxymethyl)cyclopentanol
Catalog No.:BCN5822
CAS No.:1007125-14-5
- CH5132799
Catalog No.:BCC4991
CAS No.:1007207-67-1
- 1-O-Deacetylkhayanolide E
Catalog No.:BCN5823
CAS No.:1007387-95-2
NF546 [4,4'-(carbonylbis(imino-3,1-phenylene-carbonylimino-3,1-(4-methyl-phenylene)-car bonylimino))-bis(1,3-xylene-alpha,alpha'-diphosphonic acid) tetrasodium salt] is a non-nucleotide P2Y11 agonist and stimulates release of interleukin-8 from human monocyte-derived dendritic cells.[Pubmed:19815812]
J Pharmacol Exp Ther. 2010 Jan;332(1):238-47.
The G protein-coupled P2Y(11) receptor is involved in immune system modulation. In-depth physiological evaluation is hampered, however, by a lack of selective and potent ligands. By screening a library of sulfonic and phosphonic acid derivatives at P2Y(11) receptors recombinantly expressed in human 1321N1 astrocytoma cells (calcium and cAMP assays), the selective non-nucleotide P2Y(11) agonist NF546 [4,4'-(carbonylbis(imino-3,1-phenylene-carbonylimino-3,1-(4-methyl-phenylene)carb onylimino))-bis(1,3-xylene-alpha,alpha'-diphosphonic acid) tetrasodium salt] was identified. NF546 had a pEC(50) of 6.27 and is relatively selective for P2Y(11) over P2Y(1), P2Y(2), P2Y(4), P2Y(6), P2Y(12), P2X(1), P2X(2), and P2X(2)-X(3). Adenosine-5'-O-(3-thio)triphosphate (ATPgammaS), a nonhydrolyzable analog of the physiological P2Y(11) agonist ATP, and NF546 use a common binding site as suggested by molecular modeling studies and their competitive behavior toward the nanomolar potency antagonist NF340 [4,4'-(carbonylbis(imino-3,1-(4-methyl-phenylene)carbonylimino))bis(naphthalene-2 ,6-disulfonic acid) tetrasodium salt] in Schild analysis. The pA(2) of NF340 was 8.02 against ATPgammaS and 8.04 against NF546 (calcium assays). NF546 was further tested for P2Y(11)-mediated effects in monocyte-derived dendritic cells. Similarly to ATPgammaS, NF546 led to thrombospondin-1 secretion and inhibition of lipopolysaccharide-stimulated interleukin-12 release, whereas NF340 inhibited these effects. Further, for the first time, it was shown that ATPgammaS or NF546 stimulation promotes interleukin 8 (IL-8) release from dendritic cells, which could be inhibited by NF340. In conclusion, we have described the first selective, non-nucleotide agonist NF546 for P2Y(11) receptors in both recombinant and physiological expression systems and could show a P2Y(11)-stimulated IL-8 release, further supporting the immunomodulatory role of P2Y(11) receptors.
